# Delineate

> Delineate is a Cambridge, Massachusetts AI company building agents that accelerate clinical trial design for pharmaceutical and biotech companies. Its custom large language models and computer vision systems extract and structure data from thousands of research papers and patents - including numbers buried inside figures and plots - turning months of manual evidence aggregation into weeks. A Y Combinator Winter 2025 company founded in 2024 by an MIT PhD and an ex-Lockheed Skunkworks AI lead, Delineate works with two top-10 pharmaceutical companies and holds an NIH STTR grant with MIT.

- **Founded:** 2024
- **Headquarters:** Cambridge, Massachusetts, United States
- **Founders:** Emily Nieves (Co-Founder & CEO), Jawad Iqbal (Co-Founder & CTO)
- **Team size:** ~20-31
- **Products:** AI evidence-aggregation agents, Model-based meta-analysis (MBMA) support, Quantitative Systems Pharmacology (QSP) acceleration
- **Notable:** Accepted into Y Combinator Winter 2025 batch, Awarded an NIH STTR Phase I grant in collaboration with MIT for QSP model development, Signed two top-10 pharmaceutical companies as customers

## Products & services

- **AI evidence-aggregation agents** — Custom LLM and computer vision models that extract and structure data from thousands of research papers and patents, including data embedded in figures and plots, delivering high-quality datasets in a fraction of the usual time.
- **Model-based meta-analysis (MBMA) support** — Tooling that assembles the aggregated evidence base underpinning model-based meta-analysis and model-informed drug development decisions such as benefit-risk and comparative efficacy assessment.
- **Quantitative Systems Pharmacology (QSP) acceleration** — Work under an NIH STTR Phase I grant with MIT to accelerate QSP model development and repurposing.

## Achievements

- Accepted into Y Combinator Winter 2025 batch
- Awarded an NIH STTR Phase I grant in collaboration with MIT for QSP model development
- Signed two top-10 pharmaceutical companies as customers
- Reported ~15x improvement in evidence-processing speed versus industry standard
- Presented at MIT Startup Exchange February 2025 Demo Day

## Latest updates

- **2025-03** — Reported seed funding around a Y Combinator W25 participation.
- **2025-02** — Presented at MIT Startup Exchange February 2025 Demo Day.
- **2025-01** — Joined Y Combinator's Winter 2025 batch.

## Links

- Website: https://delineate.pro
- LinkedIn: https://www.linkedin.com/company/delineate-pro

---

Profile page: https://yespress.io/delineate
Published by YesPress — https://yespress.io
Last updated: 2026-08-06